AJANTPHARMFinancial ResultsBSE
Board Meeting Intimation for Considering And Approving Unaudited Financial Results For Q2 FY 2027
Filed 15 October 2026 at 4:58 am · 15 Oct 2026
FILING SUBJECT
Board Meeting Intimation for Considering And Approving Unaudited Financial Results For Q2 FY 2027